OppenheimerFunds’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

OppenheimerFunds’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,870,370	Closed	-$23.3M	–	1935
2016 Q4	$23.3M	Sell	1,870,370 -550	-0%	-$6.62K	0.03%	534
2016 Q3	$25.6M	Buy	1,870,920 +10,060	+0.5%	+$101K	0.03%	503
2016 Q2	$13.8M	Hold	1,860,860	–	–	0.02%	658
2016 Q1	$11.9M	Sell	1,860,860 -1,540	-0.1%	-$8.63K	0.02%	691
2015 Q4	$11.6M	Buy	1,862,400 +9,480	+0.5%	+$62.2K	0.01%	709
2015 Q3	$10.8M	Hold	1,852,920	–	–	0.01%	703
2015 Q2	$15.3M	Hold	1,852,920	–	–	0.02%	652
2015 Q1	$15.3M	Buy	1,852,920 +232,360	+14%	+$1.72M	0.02%	656
2014 Q4	$11.1M	Hold	1,620,560	–	–	0.01%	739
2014 Q3	$8.75M	Buy	+1,620,560	New	+$9.46M	0.01%	770
2013 Q4	–	Sell	-1,000,000	Closed	-$18.4M	–	980
2013 Q3	$18.4M	Hold	1,000,000	–	–	0.02%	553
2013 Q2	$17.5M	Buy	+1,000,000	New	+$17.7M	0.03%	541

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

OppenheimerFunds's ARIA Position: Q1 2017 in Review

OppenheimerFunds sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,870,370 shares — an estimated $23.3M sold.

OppenheimerFunds first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $25.6M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

OppenheimerFunds reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
OppenheimerFunds sold 1,870,370 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $23.3M.
OppenheimerFunds first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
OppenheimerFunds's Ariad Pharmaceuticals Inc position peaked at $25.6M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on OppenheimerFunds's 13F filing for Q1 2017, filed 11 May 2017.